RedHill launches warranty program for GI medication

Biopharmaceutical company RedHill has launched a money-back warranty program for its Helicobacter pylori eradication therapy, Talicia. 

Advertisement

RedHill has committed to reimbursing patients out of pocket if the medication does not work, once patients complete the full 14-day treatment course and complete post-treatment confirmation testing, according to a March 21 news release from the company. 

Talicia is the most prescribed branded agent by gastroenterologists. H. pylori infection is the strongest known risk factor for gastric cancer, and about 35 percent of the U.S. population has it. 

More than 27,000 Americans are diagnosed with gastric cancer annually. 

This warranty program is the first of its kind for a widespread, community-treated condition, according to the release. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.